首页 | 官方网站   微博 | 高级检索  
     

ERK5和MMP-9在骨肉瘤中的表达及其临床意义
引用本文:王建澍,移志刚,蒲彦川,宋建民,耿彬,康雅琼,马淑萍,安丽萍,夏亚一.ERK5和MMP-9在骨肉瘤中的表达及其临床意义[J].中国肿瘤临床,2017,44(14):689-694.
作者姓名:王建澍  移志刚  蒲彦川  宋建民  耿彬  康雅琼  马淑萍  安丽萍  夏亚一
作者单位:①.兰州大学第二医院骨科(兰州市 730030)
基金项目:the National Natural Science Foundation of China (No. 81672207) 本文课题受国家自然科学基金(81672207)
摘    要:  目的  探讨细胞外信号调节激酶5(extracellular signal-regulated kinase 5,ERK5)蛋白和基质金属蛋白酶-9(matrix metallo proteinase-9,MMP-9)在骨肉瘤组织中的表达及其临床意义。  方法  选取71例骨肉瘤组织和40例正常骨组织,采用免疫组织化学法检测ERK5和MMP-9的表达,并分析ERK5和MMP-9的表达与骨肉瘤患者临床病理特征及预后之间的关系。  结果  骨肉瘤组织中ERK5和MMP-9阳性表达率分别为85.9%(61/71)、74.65%(53/71),均明显高于正常骨组织中阳性表达率12.5%(5/40)、10.0%(4/40),差异均具有统计学意义(均P < 0.05)。ERK5和MMP-9的阳性表达与Enneking分期和转移相关(均P < 0.05)。Ka-plan-Meier生存分析显示在骨肉瘤组织中ERK5、MMP-9的阳性表达组患者生存时间均短于阴性表达组(均P < 0.05)。单因素Cox回归分析发现,肿瘤大小、Enneking分期、转移、ERK5和MMP-9阳性表达与患者总生存时间相关(均P < 0.05);多因素分析证实Enneking分期、转移、ERK5和MMP-9蛋白的阳性表达可作为骨肉瘤患者独立的预后因子(均P < 0.05)。  结论  ERK5和MMP-9在骨肉瘤组织中高表达,与骨肉瘤的病理特征及预后相关;二者可能在骨肉瘤发生发展的过程中起着重要作用。 

关 键 词:骨肉瘤    细胞外信号调节激酶5    基质金属蛋白酶-9    免疫组织化学    预后
收稿时间:2017-02-10

ERK5 and MMP-9 expression levels in osteosarcoma and their clinical significance
Jianshu WANG,Zhigang YI,Yanchuan PU,Jianmin SONG,Bin GENG,Yaqiong KANG,Shuping MA,Liping WANG,Yayi XIA.ERK5 and MMP-9 expression levels in osteosarcoma and their clinical significance[J].Chinese Journal of Clinical Oncology,2017,44(14):689-694.
Authors:Jianshu WANG  Zhigang YI  Yanchuan PU  Jianmin SONG  Bin GENG  Yaqiong KANG  Shuping MA  Liping WANG  Yayi XIA
Affiliation:①.Department of Orthopaedics, Second Hospital of Lanzhou University, Lanzhou 730030, China②.Orthopaedics Key Laboratory of Gansu Province, Lanzhou 730030, China③.Cancer Hospital of Gansu, Lanzhou 730050, China
Abstract:Objective:To investigate the extracellular signal-regulated kinase 5 (ERK5) and matrix metallo proteinase-9 (MMP-9) expres-sion levels in osteosarcoma tissues and their clinical significance. Methods:The ERK5 and MMP-9 expression levels in 71 specimens of osteosarcoma tissue and 40 specimens of normal bone tissue were detected by immunohistochemistry. The relationship between ERK5 and MMP-9 expression levels, their clinical characteristics, and prognosis of patients with osteosarcoma were analyzed. Results:The positive expression of ERK5 and MMP-9 in osteosarcoma tissues was 85.9%(61/71) and 74.65%(53/71), respectively, which were significantly higher than those in normal bone tissues at 12.5%(5/40) and 10.0%(4/40) (all P<0.05). The positive expression of ERK5 and MMP-9 was associated with Enneking stage and metastasis (all P<0.05). Kaplan-Meier analysis showed that the survival duration of patients with positive ERK5 and MMP-9 expression levels was shorter than those of the patients in the negative expression groups (all P<0.05). Univariate analysis of COX proportional hazards regression model revealed that tumor size, Enneking stage, metastasis, and positive ERK5 and MMP-9 expression levels are relevant to the overall survival of patients with osteosarcoma (all P<0.05). Multi-variate analysis of COX proportional hazards regression model confirmed that Enneking stage, metastasis, and positive ERK5 and MMP-9 expression levels can act as independent prognostic factors for osteosarcoma patients (all P<0.05). Conclusion:The ERK5 and MMP-9 expression levels are high in osteosarcoma tissues and are related to the clinical characteristics and prognosis of patients with osteo-sarcoma. Thus, ERK5 and MMP-9 expression levels may play important roles in osteosarcoma development and progression.
Keywords:osteosarcoma  ERK5  MMP-9  immunohistochemistry  prognosis
本文献已被 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号